bepridil has been researched along with Recrudescence in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, M; Hara, S; Ito, H; Morimoto, T; Morita, H; Okawa, K; Ozaki, M; Sogo, M; Sudo, Y; Takahashi, M; Tsushima, R | 1 |
| Ayabe, R; Ebata, Y; Fukui, A; Nakagawa, M; Okada, N; Shinohara, T; Takahashi, N; Yufu, K | 1 |
| Iitsuka, K; Kato, M; Kondo, T; Miake, J; Ogura, K; Yamamoto, K | 1 |
| Aizawa, Y; Atarashi, H; Fujiki, A; Inoue, H; Ito, M; Katoh, T; Kobayashi, Y; Koretsune, Y; Kumagai, K; Niwano, S; Ogawa, S; Okazaki, O; Okumura, K; Origasa, H; Saku, K; Sato, T; Tanabe, T; Yamashita, T | 1 |
| Hagiwara, N; Hosaka, F; Naganuma, M; Shiga, T; Shoda, M; Suzuki, A | 1 |
| Hashimoto, K; Kanmatsuse, K; Masaki, R; Nakai, T; Ohkubo, K; Okumura, Y; Ozawa, Y; Saito, S; Shindo, A; Sugimura, H; Takagi, Y; Watanabe, I | 1 |
| Sugi, K | 1 |
| Fujiki, A; Inoue, H; Mizumaki, K; Nishida, K; Sakamoto, T | 1 |
| Cointe, R; Faugere, G; Gerard, R; Levy, S; Metge, M; Valeix, B | 1 |
| Aliot, E; Brembilla-Perrot, B; Clementy, J; Cosnay, P; Djiane, P; Fauchier, JP; Kacet, S; Lellouche, D; Mabo, P; Richard, M | 1 |
| Cassidy, D; Klein, GJ; Montigny, M; Roy, D; Sharma, AD | 1 |
| Cointe, R; Gérard, R; Labrunie, P; Lévy, S; Metge, M; Valeix, P | 1 |
1 review(s) available for bepridil and Recrudescence
| Article | Year |
|---|---|
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Electric Countershock; Humans; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Recurrence; Syndrome; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
4 trial(s) available for bepridil and Recrudescence
| Article | Year |
|---|---|
Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study).
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Quality of Life; Recurrence; Telecommunications; Treatment Outcome | 2009 |
Recurrence of atrial fibrillation after internal cardioversion of persistent atrial fibrillation: prognostic importance of electrophysiologic parameters.
Topics: Action Potentials; Aged; Atrial Fibrillation; Bepridil; Carbazoles; Carvedilol; Electric Countershock; Electrocardiography; Electrophysiology; Female; Heart Atria; Humans; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Propanolamines; Recurrence; Risk Factors | 2005 |
Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Bepridil; C-Reactive Protein; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Recurrence; Renin-Angiotensin System; Time Factors | 2007 |
Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens.
Topics: Administration, Oral; Adult; Aged; Bepridil; Electrophysiology; Female; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Recurrence; Stroke Volume; Tachycardia, Supraventricular | 1992 |
7 other study(ies) available for bepridil and Recrudescence
| Article | Year |
|---|---|
Effect of preprocedural pharmacologic cardioversion on pulmonary vein isolation in patients with persistent atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Bepridil; Calcium Channel Blockers; Catheter Ablation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Atria; Heart Conduction System; Humans; Male; Preoperative Care; Prospective Studies; Pulmonary Veins; Recurrence; Risk Factors; Treatment Outcome | 2021 |
Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes.
Topics: Adult; Anti-Arrhythmia Agents; Bepridil; Cilostazol; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Phosphodiesterase 3 Inhibitors; Recurrence; Tetrazoles; Treatment Outcome; Ventricular Fibrillation; Young Adult | 2014 |
Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Case-Control Studies; Catheter Ablation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Sodium Channel Blockers | 2016 |
Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiovascular Diseases; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2011 |
Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Bepridil; Cardiac Pacing, Artificial; Electrocardiography; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pyrrolidines; Recurrence; Tachycardia | 1984 |
Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias.
Topics: Administration, Oral; Adult; Bepridil; Electrophysiology; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Pyrrolidines; Recurrence; Tachycardia; Time Factors | 1987 |
[Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Bepridil; Dose-Response Relationship, Drug; Drug Evaluation; Heart Ventricles; Humans; Infusions, Parenteral; Prospective Studies; Pyrrolidines; Recurrence; Tachycardia | 1985 |